Interestingly, the lowest MHC I and MYC levels were both observed for cell lines derived from primary site lung tumor specimens and they are all high-NE tumors, whereas higher MHC I levels were observed in SCLC lines isolated from metastatic tumor samples especially those from lymph node and bone marrow. Here, MYC is linked to metastatic neoplasm.